HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Felipe Cava Selected Research

Cholera

1/2023D-amino acids signal a stress-dependent run-away response in Vibrio cholerae.
10/2022Transient Glycolytic Complexation of Arsenate Enhances Resistance in the Enteropathogen Vibrio cholerae.
11/2020Genetic Dissection of the Fermentative and Respiratory Contributions Supporting Vibrio cholerae Hypoxic Growth.
1/2020Structural basis of peptidoglycan endopeptidase regulation.
1/2019A Vibrio cholerae BolA-Like Protein Is Required for Proper Cell Shape and Cell Envelope Integrity.
1/2019Endopeptidase Regulation as a Novel Function of the Zur-Dependent Zinc Starvation Response.
12/2018Anaerobic nitrate reduction divergently governs population expansion of the enteropathogen Vibrio cholerae.
9/2017Divergent functional roles of D-amino acids secreted by Vibrio cholerae.
1/2016A cell wall damage response mediated by a sensor kinase/response regulator pair enables beta-lactam tolerance.
11/2014Cell separation in Vibrio cholerae is mediated by a single amidase whose action is modulated by two nonredundant activators.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Felipe Cava Research Topics

Disease

11Cholera
01/2023 - 06/2014
8Infections
08/2023 - 03/2013
4Hypoxia (Hypoxemia)
11/2020 - 01/2003
2Starvation
01/2019 - 01/2017
1Dehydration (Water Stress)
01/2023
1Hypersensitivity (Allergy)
01/2023
1Epilepsy (Aura)
01/2022
1Autolysis
01/2022
1Bacteremia
01/2020
1Persistent Infection
12/2019
1Respiratory Tract Diseases (Respiratory Tract Disease)
12/2019
1Hemolysis
01/2017
1Neoplasms (Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

7Anti-Bacterial Agents (Antibiotics)IBA
08/2023 - 01/2016
4EnzymesIBA
01/2023 - 06/2014
4NitratesIBA
12/2018 - 01/2003
3LactamsIBA
03/2023 - 12/2019
2Peptidoglycan (Murein)IBA
01/2023 - 01/2022
2Peptidyl Transferases (Peptidyltransferase)IBA
01/2023 - 01/2022
2MetalsIBA
01/2019 - 05/2016
2Amino AcidsFDA Link
09/2017 - 01/2017
1Penicillins (Penicillin)FDA Link
03/2023
1Arginine (L-Arginine)FDA Link
01/2023
1Lysine (L-Lysine)FDA Link
01/2023
1Protons (Proton)IBA
01/2023
1Adenosine Triphosphate (ATP)IBA
01/2023
1AcetylglucosamineIBA
01/2023
1Carbenicillin (Pyopen)FDA Link
01/2023
1arsenic acid (arsenate)IBA
10/2022
1Oxygen (Dioxygen)IBA
11/2020
1Oxidoreductases (Dehydrogenase)IBA
11/2020
1Peptide Hydrolases (Proteases)FDA Link
01/2020
1Oxacillin (Prostaphlin)FDA LinkGeneric
01/2020
1EndopeptidasesIBA
01/2019
1ZincIBA
01/2019
1HydrolasesIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Nitrite Reductases (Nitrite Reductase)IBA
12/2018
1Ligases (Synthetase)IBA
01/2017
1Guanosine PentaphosphateIBA
01/2017
1Hemolysin Proteins (Hemolysins)IBA
01/2017
1Transfer RNA (tRNA)IBA
01/2017
1Histidine KinaseIBA
01/2016
1FlagellinIBA
01/2016
1VaccinesIBA
01/2016
1Bile Acids and Salts (Bile Acids)IBA
11/2014
1Alanine (L-Alanine)FDA Link
03/2013

Therapy/Procedure

2Therapeutics
01/2019 - 01/2016